Registration - Amendment

K6 STRATEGIES, LLC for CHRYSALIS BIOTHERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Disaster Planning/Emergencies DIS

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Government Issues GOV

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Homeland Security HOM

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Budget/Appropriations BUD

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Defense DEF

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Pharmacy PHA

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Science/Technology SCI

Advocacy and lobbying to the relevant committees who have oversight for Defense, DHS, public health, energy, cience and pharmaceuticals to educate them about drug treatment being developed by Chrysalis Bio Therapeutics.

LobbyistCovered position, as disclosed
JEAN MARIE KRANZ New Senior Advisor/Staff, Congressman Pete Olson (TX-22)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.